An FDA-cleared AI software tool that analyzes standard screening mammograms (FFDM and DBT) to detect and localize breast arterial calcifications (BAC), an under-reported incidental finding linked to cardiovascular risk. It is intended for use by radiologists interpreting screening mammograms, alongside their standard breast cancer screening workflow.

iCAD (now part of DeepHealth/RadNet) develops FDA-cleared AI software for breast cancer screening, offering AI-assisted cancer detection (ProFound Detection/ProFound AI) and breast density assessment (PowerLook Density Assessment) for digital and tomosynthesis mammography, plus an investigational AI-based breast cancer risk model; it's aimed at radiologists and breast-imaging centers reading screening/diagnostic mammograms.